Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | The impact of conflict on access to cancer therapies

Richard Sullivan • 29 Apr 2024
BSH 2024
General

Richard Sullivan, PhD, MBBS, FFPM, King’s College Hospital, London, UK, provides insight into the negative impact of conflict on access to cancer therapies. In areas of conflict, the main factors affecting the provision of care are taxes against healthcare facilities and the forcible displacement of large numbers of individuals. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Richard Sullivan

1:09
Rethinking healthcare to improve affordability, sustainability, and patient outcomes
Richard Sullivan • 29 Apr 2024

Related Videos

4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
1:56
Addressing access inequality in CAR-T therapies
Francesca Del Bufalo • 15 Apr 2024
1:34
The future role of AI models in hematology and the need for high-quality data sets
Thomas Coats • 29 Apr 2024
6:38
Key papers in cardio-oncology from 2023 of relevance to hematologists
Alexander Lyon • 25 Apr 2024
The content of VJHemOnc is intended for healthcare professionals